SCHEMBL3552548

SCHEMBL3552548

CC(=O)n1cc(OCCN(C)C)c2ccccc21

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1B P28222 1/20 0.48
CREBBP Q92793 1/20 0.46
ALDH1A1 P00352 6/20 0.46
KDM4E B2RXH2 5/20 0.46
SMN1; SMN2 Q16637 3/20 0.46
NPC1 O15118 2/20 0.45
RAB9A P51151 2/20 0.45
PAX8 Q06710 2/20 0.45
JAK2 O60674 1/20 0.45
MITF O75030 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
NCOA3 Q9Y6Q9 1/20 0.45
ADRB2 P07550 1/20 0.44
ADRB1 P08588 1/20 0.44
MAPT P10636 1/20 0.43
HTR7 P34969 3/20 0.43
POLB P06746 1/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
HTR6 P50406 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6817355 0.86 HTR6 (0.52) HTR1BALDH1A1KDM4ESMN1; SMN2HTR7
SCHEMBL3562648 0.82 KDM4E (0.49) ALDH1A1KDM4ESMN1; SMN2MAPTMEN1
SCHEMBL3557948 0.82 ALDH1A1 (0.44) ALDH1A1KDM4ESMN1; SMN2MAPTHTR7
SCHEMBL3565222 0.82 KDM4E (0.49) ALDH1A1KDM4ESMN1; SMN2NPSR1MEN1
SCHEMBL6922481 0.82 HTR7 (0.49) HTR1BALDH1A1KDM4ESMN1; SMN2ADRB2
SCHEMBL3561626 0.81 MTNR1A (0.57) CREBBPALDH1A1KDM4ESMN1; SMN2HTR6
SCHEMBL24877781 0.76 HTR6 (0.58) HTR1BHTR7HTR6
SCHEMBL17023492 0.76 CREBBP (0.48) CREBBPALDH1A1KDM4ESMN1; SMN2NPC1
SCHEMBL1051164 0.75 CREBBP (0.50) CREBBPALDH1A1KDM4ESMN1; SMN2NPC1
SCHEMBL29386752 0.75 CREBBP (0.50) CREBBPALDH1A1KDM4ESMN1; SMN2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1567492-B1 N-ARYLSULFONYL-3-AMINOALKOXYINDOLES SUVEN LIFE SCIENCES LTD (IN) 2013-05-22 EP disclosed
US-7718690-B2 N-arylsulfonyl-3-aminoalkoxyindoles RAMAKRISHNA VENKATA SATYA NIROGI 2010-05-18 US disclosed
US-20090131507-A1 N-arylsulfonyl-3-aminoalkoxyindoles SUVEN LIFE SCIENCES LIMITED (IN) 2009-05-21 US disclosed
US-7507835-B2 N-arylsulfonyl-3-aminoalkoxyindoles SUVEN LIFE SCIENCES LTD. (IN) 2009-03-24 US disclosed
US-20060173193-A1 N-arylsulfonyl-3-aminoalkoxyindoles SUVEN LIFE SCIENCES LIMITED (IN) 2006-08-03 US disclosed
EP-1567492-A2 N-ARYLSULFONYL-3-AMINOALKOXYINDOLES Suven Life Sciences Limited (IN) 2005-08-31 EP disclosed
WO-2004048328-A2 N-ARYLSULFONYL-3-AMINOALKOXYINDOLES SUVEN LIFE SCIENCES LIMITED (IN) 2004-06-10 WO disclosed
WO-2004048331-A1 N-ARYLALKYL-3-AMINOALKOXYINDOLES AND THEIR USE AS 5-HT LIGANDS SUVEN LIFE SCIENCES LIMITED (IN) 2004-06-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090131507-A1 N-arylsulfonyl-3-aminoalkoxyindoles HTR3C, HTR3A, AANAT HTR1B 36/4885CREBBP 4143/4885ALDH1A1 1943/4885
US-20060173193-A1 N-arylsulfonyl-3-aminoalkoxyindoles HTR3C, HTR3A, AANAT HTR1B 36/4885CREBBP 4143/4885ALDH1A1 1943/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.